Left ventricular geometry and diastolic function in the hypertensive heart: impact of age

Francesca Negri1, Carla Sala, Annalisa Re

  • 1Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milano, Italy.

Blood Pressure
|August 3, 2012
PubMed

Insights

Aging affects how left ventricular (LV) mass and geometry relate to diastolic function in hypertensive patients. This relationship is influenced by age-related factors beyond LV mass itself.

Area of Science:

  • Cardiology
  • Gerontology
  • Echocardiography

Background:

  • The impact of aging on left ventricular (LV) mass/geometry and diastolic function is not well understood.
  • Hypertensive patients often exhibit changes in LV structure and function.

Purpose of the Study:

  • To investigate how aging influences the relationship between LV mass/geometry and diastolic function in hypertensive individuals.
  • To assess diastolic function using advanced echocardiographic methods, including tissue Doppler.

Main Methods:

  • A cohort of 660 hypertensive patients (mean age 65 ± 13 years) with preserved LV systolic function was studied.
  • Patients were divided into two age groups: <65 years and ≥65 years.
  • Comprehensive echo-Doppler examinations were performed.

Main Results:

  • Older hypertensives showed higher prevalence of LV hypertrophy (LVH), left atrial (LA) enlargement, and altered LV filling compared to younger counterparts.
  • Concentric LV geometry was more prevalent in older hypertensives.
  • In older patients, LV mass and relative wall thickness (RWT) did not correlate with diastolic indexes, unlike in younger patients.

Conclusions:

  • Aging significantly alters the relationship between LV hypertrophy and diastolic function in hypertensive patients.
  • Factors associated with aging, independent of LV mass, play a crucial role in diastolic dysfunction.
  • Standard echocardiographic assessment of LV mass may not fully capture age-related changes in diastolic function.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...